Serum adipokine levels modified by donepezil treatment in Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 38, Issue 2, 2014, Pages 371-377

  Pákáski, Magdolna ^a   Fehér, Ágnes ^a   Juhász, Anna ^a   Drótos, Gergely ^a   Fazekas, Örsike Csilla ^a   Kovács, János ^a   Janka, Zoltán ^a   Kálmán, János ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Acetylcholinesterase inhibitor; adipokine; adiponectin; Alzheimer's disease; apolipoprotein E; body weight; dementia; donepezil; leptin

Indexed keywords

ADIPONECTIN; APOLIPOPROTEIN E; DONEPEZIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; DRUG EFFECT; FEMALE; FOLLOW UP; HUMAN; MALE; OPEN STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN POLYMORPHISM; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL;

ACETYLCHOLINESTERASE INHIBITOR; ADIPOKINE; ADIPONECTIN; ALZHEIMER'S DISEASE; APOLIPOPROTEIN E; BODY WEIGHT; DEMENTIA; DONEPEZIL; LEPTIN;

ADIPOKINES; ADIPONECTIN; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CHOLINESTERASE INHIBITORS; COGNITION; FEMALE; HUMANS; INDANS; MALE; NEUROPSYCHOLOGICAL TESTS; PIPERIDINES; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 84889583003     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-131139     Document Type: Article

References (50)

1. Hogan DB (2007) Progress update: Pharmacological treatment of Alzheimer's disease. Neuropsychiatr Dis Treat 3, 569-578. (Pubitemid 350090287)
2. Inoue J, Hoshino R, Nojima H, Ishida W, Okamoto N (2010) Investigation of responders and non-responders to long-term donepezil treatment. Psychogeriatrics 10, 53-61.
3. Gauthier S, Lopez OL,Waldemar G, Jones RW, Cummings J, Zhang R, Schindler R, Schwam E (2010) Effects of donepezil on activities of daily living: Integrated analysis of patient data from studies in mild, moderate and severe Alzheimer's disease. Int Psychogeriatr 22, 973-983.
4. Beydoun MA, Beydoun HA, Wang Y (2008) Obesity and central obesity as risk factors for incident dementia and its subtypes: A systematic review and meta-analysis. Obes Rev 9, 204-218. (Pubitemid 351550691)
5. Profenno LA, Porsteinsson AP, Faraone SV (2010) Metaanalysis of Alzheimer's disease risk with obesity, diabetes, and related disorders. Biol Psychiatry 67, 505-512.
6. Erol A (2008) An integrated and unifying hypothesis for the metabolic basis of sporadic Alzheimer's disease. J Alzheimers Dis 13, 241-253. (Pubitemid 352039029)
7. Lee EB (2011) Obesity, leptin and Alzheimer's disease. Ann N Y Acad Sci 1243, 15-29.
8. Harvey J, Solovyova N, Irving A (2006) Leptin and its role in hippocampal synaptic plasticity. Prog Lipid Res 45, 369-378.
9. GustafsonDR(2012) Adiposity and cognitive decline: Underlying mechanisms. J Alzheimers Dis 30, S97-112.
10. Gillette Guyonnet S, Abellan Van Kan G, Alix E, Andrieu S, Belmin J, Berrut G, Bonnefoy M, Brocker P, Constans T, Ferry M, Ghisolfi-Marque A, Girard L, Gonthier R, Guerin O, Hervy MP, Jouanny P, Laurain MC, Lechowski L, Nourhashemi F, Raynaud-Simon A, Ritz P, Roche J, Rolland Y, Salva T, Vellas B, IANA (International Academy on Nutrition and Aging) Expert Group (2007) Weight loss and Alzheimer's disease. J Nutr Health Aging 11, 38-48.
11. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM (1994) Positional cloning of the mouse obese gene and its human homologue. Nature 372, 425-432. (Pubitemid 24365442)
12. Tezapsidis N, Johnston JM, Smith MA, Ashford JW, Casadesus G, Robakis NK,Wolozin B, Perry G, Zhu X, Greco SJ, Sarkar S (2009) Leptin: A novel therapeutic strategy for Alzheimer's disease. J Alzheimers Dis 16, 731-740.
13. Harvey J (2010) Leptin: The missing link in Alzheimer disease Clin Chem 56, 696-697.
14. Fewlass DC, Noboa K, Pi-Sunyer FX, Johnston JM, Yan SD, Tezapsidis N (2004) Obesity-related leptin regulates Alzheimer's A. FASEB J 18, 1870-1878.
15. Greco SJ, Sarkar S, Casadesus G, Zhu X, Smith MA, Ashford JW, Johnston JM, Tezapsidis N (2009) Leptin inhibits glycogen synthase kinase-3 beta to prevent tau phosphorylation in neuronal cells. Neurosci Lett 455, 191-194.
16. Lieb W, Beiser AS, Vasan RS, Tan ZS, Au R, Harris TB, Roubenoff R, Auerbach S, DeCarli C, Wolf PA, Seshadri S (2009) Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging. JAMA 302, 2565-2572.
17. Ahima RS (2006) Metabolic actions of adipocyte hormones: Focus on adiponectin. Obesity 14, 9S-15S.
18. Une K,TakeiYA,Tomita N, AsamuraT, OhruiT, Furukawa K, Arai H (2011) Adiponectin in plasma and cerebrospinal fluid in MCI and Alzheimer's disease. Eur J Neurol 18, 1006-1009.
19. Bigalke B, Schreitmuller B, Sopova K, Paul A, Stransky E, Gawaz M, Stellos K, Laske C (2011) Adipocytokines and CD34+ progenitor cells in Alzheimer's disease. Plos One 6, e20286.
20. Bayer L, Risold PY, Griffond B, Fellmann D (1991) Rat diencephalic neurons producing melanin-concentrating hormone are influenced by ascending cholinergic projections. Neuroscience 91, 1087-1101.
21. Meister B (2007) Neurotransmitters in key neurons of the hypothalamus that regulate feeding behavior and body weight. Physiol Behav 92, 263-271. (Pubitemid 47374238)
22. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders. 4. Text Revision (DSM-IV-TR).
23. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDAWork Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944. (Pubitemid 14076461)
24. Rosen WG, Mohs RC, Davis KL (1984) A new rating scale for Alzheimer's disease. Am J Psychiatry 141, 1356-1364.
25. Ṕaḱaski M, Dŕotos G, Janka Z, Ḱalḿan J (2012) Validation of the Hungarian version of Alzheimer's Disease Assessment Scale-cognitive subscale. Orv Hetil 153, 461-466 (in Hungarian).
26. Folstein MF, Folstein SE, McHugh PR (1975) Mini Mental State. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12, 189-198.
27. Janka Z, Somogyi A, Magloczky E, Pakaski M, Kalman J (1988) Dementia screening by a short cognitive test (Hungarian). Orv Hetil 129, 2797-2800.
28. Ḱalḿan J, Magĺozky E, Janka Z (1995) Disturbed visuospatial orientation in the early stage of Alzheimer's dementia. Arch Gerontol Geriatr 21, 27-34.
29. Beck AT,Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4, 561-571.
30. Ḱalḿan J, Juh́asz A, Cśasźar A, Kanka A, Magĺoczky E, Bencsik K, Janka Z, Rasḱo I (1997) Apolipoprotein E allele frequencies in patients with late-onset sporadic Alzheimer's dementia in Hungary. Acta Neurol Scand 95, 56-59. (Pubitemid 27094783)
31. Kondo T, Kobayashi I, Murakami M (2006) Effect of exercise on circulating adipokine levels in obese young women. Endocr J 53, 189-195.
32. Isidori AM, Strollo F, Mor̀e M, Caprio M, Aversa A, Moretti C, Frajese G, Rjondino G, Fabbri A (2000) Leptin and Aging: Correlation with endocrine changes in male and female healthy adult populations of different body weights. J Clin Endocrinol Metab 85, 1954-1962. (Pubitemid 32269305)
33. Havel PJ, Kasim-Karakas S, Dubuc GR, MuellerW, Phinney SD (1996) Gender difference in plasma leptin concentrations. Nat Med 2, 949-950. (Pubitemid 26306822)
34. Mori M (1997) Estrogen increases in vivo leptin production in rats and human subjects. J Endocrinol 154, 285-292. (Pubitemid 27330641)
35. Berg AH, Combs TP, Scherer PE (2002) ACRP30-adiponectin: An adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 13, 84-89. (Pubitemid 36740452)
36. KadowakiT,YamauchiT(2005) Adiponectin and adiponectin receptors. Endocr Rev 26, 439-451. (Pubitemid 40686653)
37. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA (2001) Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86, 1930-1935. (Pubitemid 32472900)
38. Combs TP, Berg AH, Rajala MW, Klebanov S, Iyengar P, Jimenez-Chillaron JC, Patti ME, Klein SL, Weinstein RS, Scherer PE (2003) Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin. Diabetes 52, 268-276. (Pubitemid 36173178)
39. Satapathy SK, Ochani M, Dancho M, Hudson LK, Rosas-Ballina M, Valdes-Ferrer SI, Olofsson PS, Harris YT, Roth J, Chavan S, Tracey KJ, Pavlov VA (2011) Galantamine alleviates inflammation and other obesity-associated complications in high-fat diet-fed mice. Mol Med 17, 599-606.
40. Marwarha G, Dasari B, Prasanthi JR, Schommer J, Ghribi O (2010) Leptin reduces the accumulation of Abeta and phosphorylated tau induced by 27-hydroxycholesterol in rabbit organotypic slices. J Alzheimers Dis 19, 1007-1019.
41. Kershaw EE, Flier JS (2004) Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89, 2548-2556. (Pubitemid 38766330)
42. Tsao TS, Lodish HF, Fruebis J (2002) ACRP30, a new hormone controlling fat and glucose metabolism. Eur J Pharmacol 440, 213-221. (Pubitemid 34458025)
43. Ḱalḿan J, Juh́asz A, Laird G, Dickens P, J́ard́anh́azy T, Rimanóczy Á , Boncz I, Parry-Jones WL, Janka Z (1997) Serum interleukin-6 levels correlate with the severity of dementia in Down syndrome and in Alzheimer's disease. Acta Neurol Scand 96, 236-240. (Pubitemid 27402491)
44. Spranger J, Verma S, G̈ohring I, Bobbert T, Seifert J, Sindler AL, Pfeiffer A, Hileman SM, Tscḧop M, Banks WA (2006) Adiponectin does not cross the blood-brain barrier but modifies cytokine expression of brain endothelial cells. Diabetes 55, 141-147. (Pubitemid 43343309)
45. Pan W, Kastin AJ (2007) Adipokines and the blood-brainbarrier. Peptides 28, 1317-1330.
46. Neumeier M,Weigert J, Buettner R,Wanninger J, Scḧaffler A, M̈uller AM, Killian S, Sauerbruch S, Schlachetzki F, Steinbrecher A, Aslanidis C, Scḧolmerich J, Buechler C (2007) Detection of adiponectin in cerebrospinal fluid in humans. Am J Physiol Endocrinol Metab 293, E965-E969. (Pubitemid 47535827)
47. Jo YH, Wiedl D, Role LW (2005) Cholinergic modulation of appetite-related synapses in mouse lateral hypothalamic slice. J Neurosci 25, 11133-11144. (Pubitemid 43089558)
48. Takada Y, Yonezawa A, Kume T, Katsuki H, Kaneko S, Sugimoto H, Akaike A (2003) Nicotinic acetylcholine receptor-mediated neuroprotection by donepezil against glutamate neurotoxicity in rat cortical neurons. J Pharmacol Exp Ther 306, 772-777. (Pubitemid 36886179)
49. Shen H, Kihara T, Hongo H, Wu X, Kem WR, Shimohama S, Akaike A, Niidome T, Sugimoto H (2010) Neuroprotection by donepezil against glutamate excitotoxicity involves stimulation of alpha7 nicotinic receptors and internalization of NMDA receptors. Br J Pharmacol 161, 127-139.
50. Wong ML, Licinio J, Yildiz BO, Mantzoros CS, Prolo P, Kling M, Gold PW (2004) Simultaneous and continuous 24-hour plasma and cerebrospinal fluid leptin measurements: Dissociation of concentrations in central and peripheral compartments. J Clin Endocrinol Metab 89, 258-265. (Pubitemid 38183891)